These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 16924643)

  • 1. First day dynamic changes in antithrombin III activity after supplementation have a predictive value in critically ill patients.
    Gando S; Sawamura A; Hayakawa M; Hoshino H; Kubota N; Oshiro A
    Am J Hematol; 2006 Dec; 81(12):907-14. PubMed ID: 16924643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antithrombin III in patients with disseminated intravascular coagulation diagnosed by newly developed diagnostic criteria for critical illness.
    Sawamura A; Gando S; Hayakawa M; Hoshino H; Kubota N; Sugano M
    Clin Appl Thromb Hemost; 2009 Oct; 15(5):561-6. PubMed ID: 18840625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-overt disseminated intravascular coagulation scoring for critically ill patients: the impact of antithrombin levels.
    Egi M; Morimatsu H; Wiedermann CJ; Tani M; Kanazawa T; Suzuki S; Matsusaki T; Shimizu K; Toda Y; Iwasaki T; Morita K
    Thromb Haemost; 2009 Apr; 101(4):696-705. PubMed ID: 19350114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum albumin levels anticipate antithrombin III activities before and after antithrombin III agent in critical patients with disseminated intravascular coagulation.
    Aibiki M; Fukuoka N; Umakoshi K; Ohtsubo S; Kikuchi S
    Shock; 2007 Feb; 27(2):139-44. PubMed ID: 17224787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombin supplementation for anticoagulation during continuous hemofiltration in critically ill patients with septic shock: a case-control study.
    du Cheyron D; Bouchet B; Bruel C; Daubin C; Ramakers M; Charbonneau P
    Crit Care; 2006; 10(2):R45. PubMed ID: 16542495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in antithrombin III activities by administration method in critical patients with disseminated intravascular coagulation: a pharmacokinetic study.
    Aibiki M; Fukuoka N; Nishiyama T; Maekawa S; Shirakawa Y
    Shock; 2007 Aug; 28(2):141-7. PubMed ID: 17515857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein C levels can be forecasted by global haemostatic tests in critically ill patients and predict long-term survival.
    Nilsson G; Astermark J; Lethagen S; Vernersson E; Berntorp E
    Thromb Res; 2005; 116(1):15-24. PubMed ID: 15850604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study.
    Nishiyama T; Kohno Y; Koishi K
    Am J Emerg Med; 2012 Sep; 30(7):1219-23. PubMed ID: 22204993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of disseminated intravascular coagulation in dogs admitted to an intensive care unit.
    Bateman SW; Mathews KA; Abrams-Ogg AC; Lumsden JH; Johnstone IB; Hillers TK; Foster RA
    J Am Vet Med Assoc; 1999 Sep; 215(6):798-804. PubMed ID: 10496131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of withdrawing antithrombin III administration from management of septic patients with or without disseminated intravascular coagulation.
    Kawano S; Uchino S; Endo A; Saito K; Iwai K; Kase Y; Takinami M
    Blood Coagul Fibrinolysis; 2014 Dec; 25(8):795-800. PubMed ID: 24806318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human antithrombin concentrates and experimental disseminated intravascular coagulation.
    Mammen EF; Miyakawa T; Phillips TF; Assarian GS; Brown JM; Murano G
    Semin Thromb Hemost; 1985 Oct; 11(4):373-83. PubMed ID: 4071063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical course and outcome of disseminated intravascular coagulation diagnosed by Japanese Association for Acute Medicine criteria. Comparison between sepsis and trauma.
    Kushimoto S; Gando S; Saitoh D; Ogura H; Mayumi T; Koseki K; Ikeda T; Ishikura H; Iba T; Ueyama M; Eguchi Y; Otomo Y; Okamoto K; Endo S; Shimazaki S;
    Thromb Haemost; 2008 Dec; 100(6):1099-105. PubMed ID: 19132236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation.
    Seo JW; Kim HK; Kim JE; Park S; Cho HI
    Thromb Res; 2009 Feb; 123(4):565-72. PubMed ID: 18479738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the coagulation cascade in patients with leptospirosis.
    Chierakul W; Tientadakul P; Suputtamongkol Y; Wuthiekanun V; Phimda K; Limpaiboon R; Opartkiattikul N; White NJ; Peacock SJ; Day NP
    Clin Infect Dis; 2008 Jan; 46(2):254-60. PubMed ID: 18171258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombin III concentrate in the treatment of DIC: a retrospective follow-up study.
    van Beek EJ; von der Möhlen MA; ten Cate JW; Brandjes DP; Büller HR
    Neth J Med; 1994 Nov; 45(5):206-10. PubMed ID: 7830846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The response of antithrombin III activity after supplementation decreases in proportion to the severity of sepsis and liver dysfunction.
    Hayakawa M; Sawamura A; Yanagida Y; Sugano M; Hoshino H; Gando S
    Shock; 2008 Dec; 30(6):649-52. PubMed ID: 18496242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity-guided antithrombin III therapy in severe surgical sepsis: efficacy and safety according to a retrospective data analysis.
    Moubarak P; Zilker S; Wolf H; Hofner B; Kneib T; Küchenhoff H; Jauch KW; Hartl WH
    Shock; 2008 Dec; 30(6):634-41. PubMed ID: 18520701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
    Levi M; Toh CH; Thachil J; Watson HG
    Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acute physiology and chronic health evaluation III outcome prediction in patients admitted to the intensive care unit after pneumonectomy.
    Keegan MT; Harrison BA; Brown DR; Whalen FX; Cassivi SD; Afessa B
    J Cardiothorac Vasc Anesth; 2007 Dec; 21(6):832-7. PubMed ID: 18068061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.